Clinical Evaluation of the Serum Free Light Chain Analysis
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Relapsed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1/2a Study of Human Anti-CD 38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Fractionated Stem Cell Infusions in Myeloma Patients Undergoing Autologous Stem Cell Transplant
- Status
- COMPLETED
- Phase
- NA
Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Vertebral Compression Fracture Fixation With RF Kyphoplasty in Patients With Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE4
Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory Disease
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Reduced Intensity Double Umbilical Cord Blood Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
- Status
- RECRUITING
- Phase
- N/A
SNP-Based Prediction of Oral Mucositis Risk in Patients Receiving Hematopoietic Stem Cell Transplants (HSCT)
- Status
- COMPLETED
- Phase
- N/A
Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE2
Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients
- Status
- COMPLETED
- Phase
- N/A
Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research
- Status
- TERMINATED
- Phase
- N/A
MAGE-A3 Protein + AS15 as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2